220829-64-1

Upstream product

• 880633-83-0 (1R,2R,3R,5S)-3,5-bis(benzyloxy)-5-(benzyloxymethyl)cyclohexane-1,2-diol 
• 101917-46-8 (3aS,4R,6R,7aR)-6-Hydroxymethyl-2,2-dimethyl-hexahydro-benzo[1,3]dioxole-4,6-diol 
• 77-95-2 D-(-)-quinic acid 
• 32384-42-2 (1S,3R,4S,5R)-3,4-O-isopropylidene-1,5-quinic lactone 
• 880633-79-4 (3aS,4R,6R,7aR)-4,6-bis(benzyloxy)-6-(benzyloxymethyl)hexahydrobenzo[d][1,3]dioxole-2-thione 
• 880633-80-7 (3R,5S)-3,5-bis(benzyloxy)-5-benzyloxymethylcyclohexene 
• 880633-81-8 (1S,3S)-1-hydroxymethylcyclohexane-1,3-diol 
• 166019-39-2 (S)-(+)-3-hydroxycyclohexanone 
• 880633-82-9 (S)-3-(tert-butyldimethylsilyloxy)cyclohexanone 
• 612820-63-0 (1R,2E,6R,7R)-2-[2-(benzothiazole-2-sulfonyl)ethylidene]-7-[(R)-6-methoxymethoxy-6-methylheptan-2-yl]-6-methylbicyclo[4.3.0]nonane 

Relevant academic research and scientific papers

Synthesis of 25-hydroxy-19-norvitamin D3 analogs and their antiproliferative activities on prostate cells

Synthesis of 25-hydroxy-19-norvitamin D3 derivatives as prohormone type agents for anti-prostate diseases was accomplished utilizing Julia-type olefination. Synthesized compounds showed potent antiproliferative activity on an immortalized norma